Amicus Therapeutics to Present at the Bank of America 2025 Health Care Conference
Amicus Therapeutics (FOLD) has announced its participation in the Bank of America 2025 Health Care Conference in Las Vegas. The company's management will engage in a fireside chat on Wednesday, May 14, 2025, at 8:00 a.m. PT. Investors and interested parties can access a live audio webcast of the presentation through the investors section of Amicus Therapeutics' corporate website.
Amicus Therapeutics is a global biotechnology company dedicated to discovering, developing, and delivering innovative medicines for rare diseases, with a strong focus on patient care and advancing their pipeline of first- or best-in-class treatments.
Amicus Therapeutics (FOLD) ha annunciato la sua partecipazione alla Bank of America 2025 Health Care Conference che si terrà a Las Vegas. Il management dell'azienda parteciperà a una conversazione informale il mercoledì 14 maggio 2025 alle 8:00 PT. Investitori e interessati potranno seguire la presentazione in diretta audio streaming tramite la sezione investitori del sito web aziendale di Amicus Therapeutics.
Amicus Therapeutics è un'azienda biotecnologica globale impegnata nella scoperta, sviluppo e distribuzione di farmaci innovativi per malattie rare, con un forte focus sulla cura del paziente e sull'avanzamento del proprio portafoglio di trattamenti di prima o migliore classe.
Amicus Therapeutics (FOLD) ha anunciado su participación en la Bank of America 2025 Health Care Conference en Las Vegas. La dirección de la compañía participará en una charla informal el miércoles 14 de mayo de 2025 a las 8:00 a.m. PT. Inversionistas y personas interesadas podrán acceder a una transmisión de audio en vivo de la presentación a través de la sección de inversores del sitio web corporativo de Amicus Therapeutics.
Amicus Therapeutics es una empresa biotecnológica global dedicada a descubrir, desarrollar y entregar medicamentos innovadores para enfermedades raras, con un fuerte enfoque en el cuidado del paciente y el avance de su cartera de tratamientos de primera o mejor clase.
Amicus Therapeutics (FOLD)가 라스베이거스에서 열리는 Bank of America 2025 Health Care Conference에 참가한다고 발표했습니다. 회사 경영진은 2025년 5월 14일 수요일 오전 8시 PT에 화상 대화에 참여할 예정입니다. 투자자 및 관심 있는 분들은 Amicus Therapeutics 기업 웹사이트의 투자자 섹션을 통해 발표의 실시간 오디오 웹캐스트를 시청할 수 있습니다.
Amicus Therapeutics는 희귀 질환을 위한 혁신적인 의약품을 발견, 개발 및 제공하는 데 전념하는 글로벌 바이오테크 회사로, 환자 치료와 최고 수준의 치료제 개발에 중점을 두고 있습니다.
Amicus Therapeutics (FOLD) a annoncé sa participation à la Bank of America 2025 Health Care Conference à Las Vegas. La direction de l'entreprise participera à une discussion informelle le mercredi 14 mai 2025 à 8h00 PT. Les investisseurs et les personnes intéressées pourront accéder à une diffusion audio en direct de la présentation via la section investisseurs du site web corporate d'Amicus Therapeutics.
Amicus Therapeutics est une entreprise biotechnologique mondiale dédiée à la découverte, au développement et à la livraison de médicaments innovants pour les maladies rares, avec un fort accent sur les soins aux patients et l’avancement de leur pipeline de traitements de première ou meilleure classe.
Amicus Therapeutics (FOLD) hat seine Teilnahme an der Bank of America 2025 Health Care Conference in Las Vegas angekündigt. Das Management des Unternehmens wird am Mittwoch, den 14. Mai 2025, um 8:00 Uhr PT an einem Gespräch am Kamin teilnehmen. Investoren und Interessierte können die Präsentation als Live-Audio-Webcast über den Investor-Bereich der Unternehmenswebsite von Amicus Therapeutics verfolgen.
Amicus Therapeutics ist ein globales Biotechnologieunternehmen, das sich der Entdeckung, Entwicklung und Bereitstellung innovativer Medikamente für seltene Krankheiten widmet, mit starkem Fokus auf Patientenversorgung und der Weiterentwicklung ihres Portfolios an erstklassigen oder besten Therapien.
- None.
- None.
PRINCETON, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Bank of America 2025 Health Care Conference in Las Vegas, NV on Wednesday, May 14, 2025, at 8:00 a.m. P.T.
A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.
CONTACT:
Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809
Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079
FOLD–G
FAQ
When is Amicus Therapeutics (FOLD) presenting at the Bank of America Healthcare Conference 2025?
How can investors watch Amicus Therapeutics' (FOLD) presentation at the Bank of America conference?
What is the main focus of Amicus Therapeutics (FOLD) as a company?
Who are the key contacts for Amicus Therapeutics (FOLD) investor relations?
